Coronavirus Disease 2019 (COVID-19)
The information provided below is current as of May 14, 2020.
Under the guidance of the US Centers for Disease Control and Prevention (CDC), Aurora Diagnostics is closely monitoring the Coronavirus 2019 (COVID-19) outbreak caused by SARS-CoV-2. Our priority is the health and safety of our employees, patients, and the communities we serve. We encourage you to periodically check this webpage for updates.
COVID-19: Information for Healthcare Providers
Aurora Diagnostics, Seacoast Pathology and LMC Pathology are now performing COVID-19 Molecular (PCR) testing and can be collected with providers’ orders. It is important to note that our Practices cannot collect respiratory (e.g. nasopharyngeal swabs) specimens for individuals who believe they have COVID-19 and are symptomatic.
Providers should not refer any patients suspected (persons under investigation) or confirmed to be infected with COVID-19 to Seacoast Pathology or LMC Pathology.
The information below provides answers to frequently asked questions.
COVID-19: Information for Patients
Aurora Diagnostics is closely monitoring the situation regarding the 2019 Novel Coronavirus (COVID-19). We are dedicated to promoting a healthy and safe environment for all our patients and employees.
Updated press releases and media statements regarding our response to COVID-19 Testing are listed below.
SARS-CoV-2/COVID-19 Update for Health Plans (30 October)
Friday 30 October 2020, 14:58
Effective October 6, 2020, the AMA CPT updated the attached SARS-CoV-2 codes to include these new codes described below, at https://www.ama-assn.org/system/files/2020-10/coronavirus-long-descriptors.pdf.
Combined respiratory virus multiplex testing for the SARS-CoV-2, influenza virus A and influenza B targets
CPT Code 87636: Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique
Net Price: $142.63
Combined respiratory virus multiplex testing for the SARS-CoV-2, influenza virus A, influenza B targets and respiratory syncytial virus (RSV)
CPT Code 87637: Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique
Net Price: $142.63
SARS-CoV-2/COVID-19 Update for Health Plans (20 May 2020)
Tuesday 20 May 2020, 13:00 | Aurora Diagnostics
Update for Health Plans: New Pricing and CPT Code Information
Name of Test CPT Code Net Price (Expected Net Reimbursement)
|Name of Test
||Net Price (Expected Net Reimbursement)
|SARS-CoV-2/COVID-19, High throughput
*Effective May 20, 2020, Sonic Healthcare USA Anatomic Pathology Division, Aurora Diagnostics, have begun performing Molecular (PCR) tests for COVID-19. In response to this national health crisis and to ensure optimal access for patients, we are offering a single price for all payers.
- – As for all COVID-19 tests, Aurora uses multiple platforms and methodologies for molecular (PCR) testing in order to:
- – maintain critical turnaround time commitment.
- – prevent service interruptions due to platform-specific supply chain issues.
- – resolve indeterminate results or inconsistencies between test results and clinical presentation.
- – All tests have received Emergency Use Authorization (EUA) by the FDA.